Covid: Vaccine study links virus to rare neurological illness

Rare neurological conditions may occur after Covid vaccination, but the risk is far higher in people who catch Covid, new research suggests.

Doctors say the landmark UK study provides further reassurance that being vaccinated offers the best protection for overall health.

The investigators examined the NHS records of 32 million adults in England to assess any rare adverse events linked to Covid vaccines.

The scientists, from the Universities of Oxford and Edinburgh, compared the levels of neurological conditions seen within a month of having a first Covid jab, to those seen within a month of a positive coronavirus test.

One thing they looked for was a rare condition called Guillain-Barre Syndrome (GBS) known to be associated with certain infectious diseases and linked to some other vaccines.

GBS causes inflammation of the nerves and can lead to numbness, weakness and pain, usually in the feet, hands and limbs and can spread to the chest and face.

It can be treated and most people will eventually make a full recovery, but it can be very serious and even life-threatening for some.

In the study, following the first dose of vaccine, there were:

Meanwhile for people who had a coronavirus infection, there were approximately:

There was also an increased risk of bleeds on the brain in the first seven days after a positive Covid test, but risks returned to a normal, baseline level within a month.

Researchers repeated their study on a smaller population of vaccinated adults in Scotland and found the same link with GBS and the Astrazeneca vaccine. They did not see the same pattern of increased risks with the Pfizer jab.

They say it remains unclear why these links appear and suggest more studies are needed to understand this.

Prof Julia Hippisley-Cox, from the University of Oxford, said: "The really big message from this is these are very rare neurological events that might be associated with the vaccine.

"But there is overwhelming evidence of the effectiveness of the vaccine against serious illness.

"I also work as a GP and we want to make sure people are taking up the vaccine and booster jabs, and by doing that we will protect the health of the nation in the best way we can."

Prof Peter Openshaw, of Imperial College London, agreed the study showed a small increased risk after vaccination.

He added: "However, these adverse events were dwarfed by the neurological disorders seen after testing positive for Covid.

"Guillain-Barre syndrome, myasthenia-like disease, subarachnoid haemorrhage, encephalitis, and Bell's palsy were all quite common, especially in the first two weeks after testing positive for Sars-Cov-2."

Researchers hope to expand their study to consider second vaccine doses and booster doses.